JUNTOMRI Trademark

Trademark Overview


On Friday, August 27, 2021, a trademark application was filed for JUNTOMRI with the United States Patent and Trademark Office. The USPTO has given the JUNTOMRI trademark a serial number of 90906338. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, March 7, 2024. This trademark is owned by ACADIA Pharmaceuticals, Inc.. The JUNTOMRI trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders

Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals

Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders

Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing in the nature of pharmaceutical testing, namely, in vitro and in vivo preclinical testing of potential drugs and consultation related thereto; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
juntomri

General Information


Serial Number90906338
Word MarkJUNTOMRI
Filing DateFriday, August 27, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, March 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders
Goods and ServicesPromoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals
Goods and ServicesMedical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders
Goods and ServicesScientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing in the nature of pharmaceutical testing, namely, in vitro and in vivo preclinical testing of potential drugs and consultation related thereto; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameACADIA Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameACADIA Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Friday, March 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 7, 2024SOU EXTENSION 2 GRANTED
Thursday, March 7, 2024SOU EXTENSION 2 FILED
Thursday, March 7, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 22, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 22, 2023SOU EXTENSION 1 FILED
Tuesday, August 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, November 30, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 30, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, November 30, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, June 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 1, 2022ASSIGNED TO EXAMINER
Thursday, September 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 31, 2021NEW APPLICATION ENTERED